Search the Newsreel

Morgan Stanley (ABUS) units report near-9% Arbutus Biopharma stake in 13G/A filing

Morgan Stanley and Morgan Stanley Investment Management Inc. have disclosed significant beneficial ownership in Arbutus Biopharma Corp (ABUS) common shares through a Schedule 13G/A filing. As of June 30, 2026, Morgan Stanley reporting units beneficially own 8.8% of Arbutus Biopharma's common shares, while Morgan …

Stanley Black & Decker (SWK) investirá US$ 1 bilhão nos EUA até 2028

Morgan Stanley Files Bitcoin ETF With 0.14% Fee

Morgan Stanley has filed an amended S-1 registration statement for its spot Bitcoin ETF, proposing a 0.14% annual fee, which is lower than all current U.S. competitors, including BlackRock's 0.25%. This move is expected to facilitate recommendations from its extensive network of financial advisors, …

Morgan Stanley Warns Investors Underestimating SpaceX’s AI Unit

Morgan Stanley analysts believe investors are significantly undervaluing SpaceX's AI business, including its neocloud partnerships and the impact of its Cursor acquisition. They project Cursor's annual revenue run rate to reach $33 billion by 2030, suggesting that as more details emerge about the Cursor/Grok …

Morgan Stanley Has Lowered Expectations for American Homes 4 Rent (NYSE:AMH) Stock Price

Morgan Stanley reduced its price target for American Homes 4 Rent (NYSE:AMH) from $38.50 to $38.00, while maintaining an "overweight" rating, suggesting a 12.7% upside. Despite this, the overall analyst sentiment remains positive with a "Moderate Buy" consensus and an average target of $36.78. …

Amentum Needs Revenue Growth to Re-rate Higher, Morgan Stanley Says

Morgan Stanley suggests that Amentum (AMTM) requires increased revenue growth to achieve a higher valuation. The company's fiscal Q3 revenue fell short of estimates, despite continued profitability. A premium subscription is needed to access the full article details.

Stanley Black & Decker outlines $1 billion U.S. investment through 2028

Stanley Black & Decker ©Stanley Black & Decker Stanley Black & Decker (NYSE:SWK) plans to invest $1 billion across its U.S. operations through 2028, with spending focused on research and development, manufacturing capabilities and workforce development. The New Britain, Connecticut-based company said the programme …

Stanley Black & Decker plans $1B U.S. investment through 2028 By Investing.com

Stanley Black & Decker announced a $1 billion investment in the United States through 2028, divided equally between research and development for tool innovation and capital expenditures for manufacturing. The investment aims to address workforce needs in the construction sector and includes a commitment …

Stanley Black & Decker Investing $1 Billion in the U.S. to Drive Innovation, Strengthen U.S. Manufacturing Footprint and Expand the Skilled Trades Workforce Essential to Building America's Infrastructure

Stanley Black & Decker is investing $1 billion in the U.S. to boost innovation, enhance its manufacturing capabilities, and expand the skilled trades workforce. This investment aims to develop next-generation tools, strengthen U.S. production, and address the critical shortage of skilled workers in the …

Morgan Stanley Adjusts Agilent Technologies PT to $175 From $160, Maintains Overweight Rating

Morgan Stanley has increased its price target for Agilent Technologies (A) to $175, up from $160, while reiterating an Overweight rating on the stock. This adjustment reflects a positive outlook for the company's financial performance and market position.

Hunt Midwest sells massive KCI-area facility for $158.5M

Hunt Midwest has sold a large facility located in its KCI 29 Logistics Park for $158.5 million to Morgan Stanley. The building houses an Ace Hardware retail support center, and Ace's long-term lease was a major factor in the acquisition. This facility was the …

Insight Wealth Strategies LLC Boosts Holdings in Stanley Black & Decker, Inc. $SWK

Insight Wealth Strategies LLC significantly increased its stake in Stanley Black & Decker, Inc. (NYSE:SWK) by 20.6% in the second quarter, bringing its total holdings to 84,301 shares valued at $7.7 million. Other institutional investors also adjusted their positions in the company, which recently …

Morgan Stanley Adjusts PT on Camden Property Trust to $118 From $120, Keeps Equalweight Rating

Morgan Stanley has revised its price target for Camden Property Trust (CPT) to $118, down from $120, while maintaining an "Equalweight" rating on the stock. This adjustment reflects a moderated outlook for the residential REIT. Other recent analyst actions include BNP Paribas adjusting its …

Morgan Stanley Adjusts PT on American International to $81 From $82, Maintains Equalweight Rating

Morgan Stanley has lowered its price target for American International Group (AIG) to $81 from $82, while keeping an "Equalweight" rating on the stock. This adjustment reflects a minor change in the firm's outlook for the insurance giant. The article also lists recent analyst …

Annex Advisory Services LLC Has $70.18 Million Stake in Morgan Stanley $MS

Assenagon Asset Management S.A. Buys 81,121 Shares of Stanley Black & Decker, Inc. $SWK

Assenagon Asset Management S.A. significantly increased its stake in Stanley Black & Decker, Inc. (NYSE:SWK) by 533.7%, purchasing an additional 81,121 shares. This brings their total holding to 96,322 shares, valued at approximately $9.07 million. The company's stock currently holds a consensus "Hold" rating …

Morgan Stanley Adjusts PT on Immix Biopharma to $19 From $20, Maintains Overweight Rating

Morgan Stanley has adjusted its price target for Immix Biopharma (IMMX) from $20 to $19, while maintaining an Overweight rating on the stock. This revision suggests a slight change in the bank's valuation outlook for the biopharmaceutical company.

Arkham Unmasks Morgan Stanley's MSBT Wallets Behind $87M Bitcoin ETF

Arkham, a blockchain analytics firm, has identified the on-chain wallets for Morgan Stanley's newly launched spot Bitcoin ETF (MSBT), providing public transparency on its holdings. The MSBT ETF began trading on April 8, 2026, and quickly accumulated $87 million in net assets, offering a …

Why Morgan Stanley (MS) Is Back In The Spotlight

Demolition begins for billion-dollar Uptown tower that could host Morgan Stanley office hub

Demolition has commenced for a billion-dollar tower in Uptown Dallas, which is speculated to become a major office hub for Morgan Stanley. The project signifies a significant development in the area's commercial real estate market, potentially bringing a high-profile financial institution to a new, …

Demolition clears way for billion-dollar Uptown tower that Morgan Stanley wants

A former Gold's Gym in Dallas has been demolished, paving the way for a potential high-rise development that investment banking giant Morgan Stanley is eyeing for a new regional hub. The Dallas City Council previously approved an $18.5 million incentive package for the project, …

Morgan Stanley raises Bicara Therapeutics stock price target on cash runway

Morgan Stanley has increased its price target for Bicara Therapeutics (NASDAQ:BCAX) from $37 to $39, maintaining an Overweight rating due to the company's strong cash position. Bicara reported $497.3 million in cash and equivalents, projected to fund operations into the first half of 2029, …

Stanley Black & Decker Inc. stock outperforms competitors on strong trading day

Stanley Black & Decker Inc. (SWK) saw its stock rise by 1.33% to $104.00, outperforming the broader market which experienced a grim trading session. The S&P 500 Index and Dow Jones Industrial Average both fell. The company's stock closed just below its 52-week high.

Morgan Stanley Adjusts PT on ACADIA Pharmaceuticals to $27 From $26, Maintains Equalweight Rating

Morgan Stanley has increased its price target for ACADIA Pharmaceuticals (ACAD) from $26 to $27, while maintaining an Equalweight rating on the stock. This adjustment reflects a modest positive outlook on the company's valuation by the firm.

Hims & Hers Health Sees Mixed Q2 as Gross Margin, FCF Weigh, Morgan Stanley Says

Hims & Hers Health reported a mixed Q2, with its US business showing upside. However, gross margin and free cash flow were identified as weighing factors, according to Morgan Stanley. The full article is premium content, requiring a subscription to read.

Erste Group Bank Comments on Morgan Stanley FY2027 Earnings

Morgan Stanley Real Estate Investing Acquires Ace Hardware Distribution Facility in Kansas City From Hunt Midwest for $158.5 Million

NEW YORK, August 11, 2026--(BUSINESS WIRE)--Morgan Stanley Investment Management, through investment funds managed by Morgan Stanley Real Estate Investing (MSREI), announced today the acquisition of a newly developed, 1.5 million-square-foot distribution facility in Kansas City, Missouri, for $158.5 million. The property was acquired from …

AXSOME THERAPEUTICS, INC. : MORGAN STANLEY RAISES TARGET PRICE TO $251 FROM $242

Morgan Stanley has increased its target price for Axsome Therapeutics, Inc. (AXSM) to $251 from $242. This update reflects an analyst's revised valuation for the company. The article, sourced from Reuters, provides this key financial adjustment.

Is Stronger Profitability, Higher EPS Guidance And Buybacks Altering The Investment Case For Stanley Black & Decker (SWK)?

Morgan Stanley's big French M&A guy didn't want to be a chairman forever, then

Jean-Baptiste Charlet, formerly chairman of investment banking for France at Morgan Stanley, has moved to Citi as country officer and head of banking for France. This move suggests a preference for a more hands-on, strategy-focused role over a pure chairman position, which is often …

Morgan Stanley sees more upside in these stocks as 'chipflation' worsens

Rapid demand and subsequent higher prices for memory chips are unlikely to end anytime soon, Morgan Stanley warns. The call: Morgan Stanley analyst Erik Woodring caught our attention with a new note out on Tuesday on ways to play the memory chip price increase. …

How Could Morgan Stanley (MS) Shape U.S. Growth With Its $1.5 Trillion Initiative?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Morgan Stanley (NYSE:MS) has launched the U.S. Innovation Infrastructure Initiative, targeting approximately US$1.5t in capital to support American growth. The program focuses on …

Handelsbanken Fonder AB Acquires 67,900 Shares of Morgan Stanley $MS

Morgan Stanley raises TaskUs stock price target to $7 on estimates

Morgan Stanley increased its price target for TaskUs (NASDAQ:TASK) stock to $7 from $6, maintaining an Equalweight rating, despite slightly lowering its 2026 and 2027 revenue and adjusted EBITDA estimates. The revision is attributed to outperformance in Q2 2026 being offset by META automation …

Morgan Stanley Direct Lending Fund (NYSE:MSDL) Receives Consensus Recommendation of "Hold" from Brokerages

Morgan Stanley Direct Lending Fund (MSDL) has received a consensus "Hold" rating from seven brokerages, with an average 12-month price target of $15.625. Institutional investors have notably increased their holdings in MSDL, while the company reported quarterly EPS in line with estimates at $0.45 …

KMG Fiduciary Partners LLC Sells 8,693 Shares of Morgan Stanley $MS